References
- Huh J (2012) Epidemiologic overview of malignant lymphoma. Korean J Hematol 47, 92-104 https://doi.org/10.5045/kjh.2012.47.2.92
- Smith A, Crouch S, Lax S et al (2015) Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network. Br J Cancer 112, 1575-1584 https://doi.org/10.1038/bjc.2015.94
- Shanbhag S and Ambinder RF (2018) Hodgkin lymphoma: A review and update on recent progress. CA Cancer J Clin 68, 116-132 https://doi.org/10.3322/caac.21438
- Armitage JO, Gascoyne RD, Lunning MA and Cavalli F (2017) Non-Hodgkin lymphoma. Lancet 390, 298-310 https://doi.org/10.1016/S0140-6736(16)32407-2
- Zeng J and Li D (2004) Expression and purification of his-tagged rat peroxisomal acyl-CoA oxidase I wild-type and E421 mutant proteins. Protein Expr Purif 38, 153-160 https://doi.org/10.1016/j.pep.2004.08.013
- Fournier B, Saudubray JM, Benichou B et al (1994) Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy. J Clin Invest 94, 526-531 https://doi.org/10.1172/JCI117365
- Fan CY, Pan J, Chu R et al (1996) Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem 271, 24698-24710 https://doi.org/10.1074/jbc.271.40.24698
- Fan CY, Pan J, Usuda N, Yeldandi AV, Rao MS and Reddy JK (1998) Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J Biol Chem 273, 15639-15645 https://doi.org/10.1074/jbc.273.25.15639
- Huang J, Viswakarma N, Yu S et al (2011) Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol 179, 703-713 https://doi.org/10.1016/j.ajpath.2011.04.030
- Melino G, De Laurenzi V and Vousden KH (2002) p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2, 605-615 https://doi.org/10.1038/nrc861
- Oberst A, Rossi M, Salomoni P et al (2005) Regulation of the p73 protein stability and degradation. Biochem Biophys Res Commun 331, 707-712 https://doi.org/10.1016/j.bbrc.2005.03.158
- Nemajerova A, Petrenko O, Trumper L, Palacios G and Moll UM (2010) Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice. J Clin Invest 120, 2070-2080 https://doi.org/10.1172/JCI40331
- Zorova LD, Popkov VA, Plotnikov EY et al (2018) Mitochondrial membrane potential. Anal Biochem 552, 50-59 https://doi.org/10.1016/j.ab.2017.07.009
- Chao C, Herr D, Chun J and Xu Y (2006) Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. EMBO J 25, 2615-2622 https://doi.org/10.1038/sj.emboj.7601167
- Jones EV, Dickman MJ and Whitmarsh AJ (2007) Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem J 405, 617-623 https://doi.org/10.1042/BJ20061778
- Antonenkov VD, Grunau S, Ohlmeier S and Hiltunen JK (2010) Peroxisomes are oxidative organelles. Antioxid Redox Signal 13, 525-537 https://doi.org/10.1089/ars.2009.2996
- Dahabieh MS, Di Pietro E, Jangal M et al (2018) Peroxisomes and cancer: The role of a metabolic specialist in a disease of aberrant metabolism. Biochim Biophys Acta Rev Cancer 1870, 103-121 https://doi.org/10.1016/j.bbcan.2018.07.004
- Dahabieh MS, Ha Z, Di Pietro E et al (2017) Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis. Cell Death Differ 24, 1912-1924 https://doi.org/10.1038/cdd.2017.115
- Ferdinandusse S, Denis S, Hogenhout EM et al (2007) Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat 28, 904-912 https://doi.org/10.1002/humu.20535
- Yu S, Rao S and Reddy JK (2003) Peroxisome proliferatoractivated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med 3, 561-572 https://doi.org/10.2174/1566524033479537
- Hashimoto T, Fujita T, Usuda N et al (1999) Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 274, 19228-19236 https://doi.org/10.1074/jbc.274.27.19228
- Rossi M, De Laurenzi V, Munarriz E et al (2005) The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 24, 836-848 https://doi.org/10.1038/sj.emboj.7600444
- Miyazaki K, Ozaki T, Kato C et al (2003) A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity. Biochem Biophys Res Commun 308, 106-113 https://doi.org/10.1016/S0006-291X(03)01347-0
- Asher G, Tsvetkov P, Kahana C and Shaul Y (2005) A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19, 316-321 https://doi.org/10.1101/gad.319905
- Agami R, Blandino G, Oren M and Shaul Y (1999) Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 399, 809-813 https://doi.org/10.1038/21697
- Zheng F, Yue C, Li G et al (2016) Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat Commun 7, 10180 https://doi.org/10.1038/ncomms10180
- Zheng FM, Long ZJ, Hou ZJ et al (2014) A novel small molecule aurora kinase inhibitor attenuates breast tumor-initiating cells and overcomes drug resistance. Mol Cancer Ther 13, 1991-2003 https://doi.org/10.1158/1535-7163.MCT-13-1029